Vita Salsman

Vita Sophia Salsman brings more than two decades of experience at the intersection of cancer immunotherapy, cell therapy manufacturing, and clinical operations. Her career spans foundational work at Baylor College of Medicine’s Center for Cell and Gene Therapy — where she contributed to over 400 patient treatments across more than 15 concurrent Phase I/II oncology trials — through senior executive roles overseeing GMP manufacturing, CMC regulatory strategy, and FDA interactions for cutting-edge cell therapy programs.

Vita has deep hands-on expertise in immunotherapy and T cell-based approaches, with a track record of translating complex scientific platforms from the laboratory into clinical reality. Her work bridges the full spectrum of development: from manufacturing process design and quality assurance to regulatory submissions and direct patient care. This rare combination of scientific rigor, operational leadership, and genuine commitment to patient outcomes informs every aspect of her work.